Device type · QYX
Outpatient Cardiac Telemetry
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QYX
Cardiovascular
Device class
Class II
FDA decisions since 2015
9
510(k), De Novo and PMA
Adverse event reports
76
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Outpatient Cardiac Telemetry
- Product code
- QYX
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1025
- Specialty
- Cardiology, Electrophysiology
- FDA record
- Classification database entry for QYX
Latest FDA decisions
The 8 newest of 9 since 2015.
- RhythmStar System (SL)510(k)
K250793 · Decided Apr 21, 2026 · 403 days after receipt
Device type: Outpatient Cardiac Telemetry (QYX) · Cardiology
K241179 · Decided Jul 11, 2025 · 438 days after receipt
Device type: Outpatient Cardiac Telemetry (QYX) · Cardiology
K240653 · Decided Oct 31, 2024 · 238 days after receipt
Device type: Outpatient Cardiac Telemetry (QYX) · Cardiology
K240029 · Decided Oct 21, 2024 · 291 days after receipt
Device type: Outpatient Cardiac Telemetry (QYX) · Cardiology
- RhythmStar System510(k)
K233584 · Decided Jul 8, 2024 · 244 days after receipt
Device type: Outpatient Cardiac Telemetry (QYX) · Cardiology
- NOWCARDIO SYSTEM510(k)
Contex International Technologies (Canada), Inc.
K162956 · Decided Sep 22, 2017 · 333 days after receipt
Device type: Outpatient Cardiac Telemetry (QYX) · Cardiology
K170565 · Decided Aug 1, 2017 · 155 days after receipt
Device type: Outpatient Cardiac Telemetry (QYX) · Cardiology
K163512 · Decided Jun 2, 2017 · 169 days after receipt
Device type: Outpatient Cardiac Telemetry (QYX) · Cardiology
Reports received
76
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
49
64% of reports
Injury reports
26
34% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 57 | 1 | 0 | 0 |
| Jan 24 | 37 | 1 | 3 | 0 |
| Feb 24 | 34 | 2 | 2 | 0 |
| Mar 24 | 40 | 0 | 3 | 0 |
| Apr 24 | 55 | 2 | 0 | 0 |
| May 24 | 63 | 0 | 0 | 0 |
| Jun 24 | 87 | 1 | 2 | 0 |
| Jul 24 | 6 | 1 | 0 | 0 |
| Aug 24 | 14 | 2 | 0 | 0 |
| Sep 24 | 9 | 1 | 0 | 0 |
| Oct 24 | 10 | 2 | 0 | 0 |
| Nov 24 | 5 | 3 | 1 | 0 |
| Dec 24 | 13 | 0 | 1 | 0 |
| Jan 25 | 7 | 1 | 0 | 0 |
| Feb 25 | 6 | 5 | 0 | 0 |
| Mar 25 | 9 | 1 | 1 | 0 |
| Apr 25 | 10 | 2 | 0 | 0 |
| May 25 | 7 | 1 | 0 | 0 |
| Jun 25 | 1 | 3 | 0 | 0 |
| Jul 25 | 8 | 4 | 0 | 0 |
| Aug 25 | 4 | 4 | 0 | 0 |
| Sep 25 | 3 | 9 | 0 | 0 |
| Oct 25 | 2 | 2 | 0 | 0 |
| Nov 25 | 4 | 2 | 0 | 0 |
| Dec 25 | 5 | 9 | 0 | 0 |
| Jan 26 | 9 | 1 | 0 | 0 |
| Feb 26 | 6 | 5 | 0 | 0 |
| Mar 26 | 3 | 1 | 0 | 0 |
| Apr 26 | 9 | 5 | 0 | 0 |
| May 26 | 2 | 3 | 0 | 0 |
| Jun 26 | 8 | 0 | 0 | 0 |
| Jul 26 | 2 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 1 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Failure to Transmit Record46
- Patient-Device Incompatibility27
- Fire1
- Patient Data Problem1
- Patient Device Interaction Problem1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Unspecified Heart Problem48
- Skin Inflammation/ Irritation22
- Hypersensitivity/Allergic reaction7
- Contact Dermatitis3
- No Clinical Signs, Symptoms or Conditions2
- Blister1
- Burn(s)1
- Burning Sensation1
- Pain1
- Swelling/ Edema1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls for this product code in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.